Journal profile · RHEUMATOLOGY
Egyptian Rheumatologist
ISSN 1110-1164 · eISSN 2090-2433 · Elsevier · Egypt
Egyptian Rheumatologist: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.8 (journal website); fully open access; APC about USD 1,500; review about 13 days (submission to acceptance, publisher); 54 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Egyptian Rheumatologist is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Spondyloarthritis Studies and Treatments, together about 38.9% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Produced and hosted on behalf of the Egyptian Society of Rheumatic Diseases. Peer review under the responsibility of the Egyptian Society of Rheumatic DiseasesThe Egyptian Rheumatologist is the official journal of the Egyptian Society of Rheumatic Diseases. The journal is published quarterly. It publishes original papers within the various fields of rheumatology. Articles in the field of physical medicine and rehabilitation will be accepted on condition that they are related to rheumatic and connective tissue diseases.
From the journal's Aims & Scope
Research area (LetPub): RHEUMATOLOGY
Editor-in-chief Bassel El-ZorkanyPublisher website
Editorial board by country: none in mainland China; most named Egypt 19, Germany 3, France 3, United States 2, United Kingdom 1 (32 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Systemic Lupus Erythematosus ResearchMedicine19.2%
- Rheumatoid Arthritis Research and TherapiesMedicine12.1%
- Spondyloarthritis Studies and TreatmentsMedicine7.7%
- Autoimmune and Inflammatory Disorders ResearchMedicine6.7%
- Systemic Sclerosis and Related DiseasesMedicine4.1%
- Psoriasis: Treatment and PathogenesisImmunology and Microbiology3.9%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.8%
- Human auditory perception and evaluationEngineering3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.8Publisher website ·
- CiteScore 2026-06
- 2.5LetPub ·
- CiteScore (publisher)
- 2.5Publisher website ·
- SJR 2026-06
- 0.31LetPub ·
- SNIP 2026-06
- 0.54LetPub ·
- h-index
- 28OpenAlex ·
- i10-index
- 231OpenAlex ·
- 2-year mean citedness
- 0.84OpenAlex ·
- Self-citation rate
- 37.5%LetPub ·
- Share of gold OA articles
- 31.47%LetPub ·
Volume
- Articles per year
- 51LetPub ·
Articles by year OpenAlex count · 826 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 26 | 4 | 2 |
| 2025 | 54 | 1 | 36 |
| 2024 | 49 | 5 | 71 |
| 2023 | 51 | 45 | 122 |
| 2022 | 57 | 57 | 290 |
| 2021 | 75 | 75 | 376 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
13 dayssubmission to acceptance · community reports about 39 weeks
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Average review time (community reports)
- about 39 weeksLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 13 daysPublisher website ·
- Submission to acceptance
- 13 daysPublisher website ·
- Acceptance to publication
- 8 daysPublisher website ·
- Peer review
- Double blind peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 1,500 / EUR 1,400 / GBP 1,200 / JPY 186,050 | — | — | |
| LetPub | No APC | Yes | — | |
| Publisher website | USD 1,880 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Suggested reviewers
- Required
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Author contributions
For transparency, we encourage corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administratio…
Source ↗Publisher website ·- Conflicts of interest Conflict of interest
All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. See also https://www.elsevier.com/conflictsofint…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Egypt
- Language
- English
- ISSN
- 1110-1164
- Electronic ISSN
- 2090-2433
- Society / sponsor
- Egyptian Society of Rheumatic Diseases
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Egyptian Rheumatologist
What CAS zone is Egyptian Rheumatologist in?
In the 2025 upgraded edition of the CAS Journal Ranking, Egyptian Rheumatologist is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Egyptian Rheumatologist?
The journal's website gives an impact factor of 0.8; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.5, h-index 28.
How long does peer review take at Egyptian Rheumatologist?
The publisher reports about 13 days (submission to acceptance); authors report an average review time of about 39 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Egyptian Rheumatologist?
According to the journal's author guidelines: Abstract: ≤ 250 words; Suggested reviewers: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Egyptian Rheumatologist based?
Of the 32 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Egypt (19), Germany (3) and France (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Egyptian Rheumatologist?
According to LetPub and DOAJ records, Egyptian Rheumatologist is indexed in ESCI and Scopus.
Is Egyptian Rheumatologist open access, and what is the APC?
Egyptian Rheumatologist is a fully open-access journal. APC about USD 1,500.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .